Treatment of hemolytic anemia with danazol
US4837212A · kind A · utility
8Cited by
1References
2Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 1, 1986 |
| Grant date | Jun 6, 1989 |
| Priority date | — |
| Expiry date | Dec 1, 2006 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/58
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Danazol, a known androgen, is used to (1) correct immune abnormalities associated with hemotologic disorders or (2) treating immune disorders associated with depressed T helper cells, in the invention disclosed.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.